| Health / Medical Topics |
DEPDC1/MPHOSH1 Peptide Vaccine
A cancer vaccine containing HLA-A*2402-restricted epitopes derived from DEP domain containing 1 (DEPDC1) and M phase phosphoprotein 1 (MPHOSPH1) with potential immunostimulatory and antineoplastic activities. Upon administration, DEPDC1/MPHOSH1 peptide vaccine may elicit a specific cytotoxic T lymphocyte (CTL) response against tumor cells expressing DEPDC1 and MPHOSPH1, tumor antigens that are overexpressed in bladder cancer cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
The act of leaving a destination.
The U.S. federal government agency responsible for protecting the public’s health and providing important services, especially for people in need. The Department…
Department of Defense (DOD). According to the FY2004 Defense Appropriations Act, DOD is responsible for funding of several cancer research programs such…
A specialized division of a large organization.
A drug used to treat epileptic seizures and bipolar disorder and to prevent migraine headaches. It is also being studied in the…
DEP domain-containing mTOR-interacting protein (409 aa, ~46 kDa) is encoded by the human DEPTOR gene. This protein plays a role in the…
